Torrent Pharmaceuticals denies counterfeit allegations around Shelcal 500

Pallavi Madhiraju- September 26, 2024 0

Torrent Pharmaceuticals Limited, one of India’s leading pharmaceutical companies, has strongly refuted claims surrounding the quality of its popular product Shelcal 500. In a statement ... Read More

Torrent Pharmaceuticals licenses Vonoprazan from Takeda to treat GERD in India

Pallavi Madhiraju- June 6, 2024 0

Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), in ... Read More

Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health

Pallavi Madhiraju- November 10, 2023 0

Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis ... Read More

Torrent Pharmaceuticals Q1 FY24 snapshot: 10% surge in revenue amid resilient Germany performance

Pallavi Madhiraju- August 7, 2023 0

Torrent Pharmaceuticals, a key player in the pharmaceutical landscape, has publicized its financial figures for Q1 FY24, showcasing a solid 10% revenue growth, touching Rs. ... Read More

Torrent Pharmaceuticals wraps up Rs 20bn acquisition of Curatio Healthcare

Pallavi Madhiraju- October 15, 2022 0

Torrent Pharmaceuticals said that it has wrapped up the previously announced INR 2,000 crores acquisition of Curatio Healthcare (I) Private Limited, a cosmetic dermatology company. ... Read More

Torrent Pharmaceuticals to acquire dermatology company Curatio Healthcare for Rs 20bn

Pallavi Madhiraju- September 28, 2022 0

Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for INR 2,000 crores, in a move to ... Read More

Torrent Pharma buys Styptovit-E, Finast, and other brands from Dr. Reddy’s

pallavi123- May 29, 2022 0

Torrent Pharmaceuticals has agreed to acquire the Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr. Reddy's Laboratories for an undisclosed price. Styptovit-E is a gynecology ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

pallavi123- March 18, 2022 0

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial

pallavi123- June 29, 2021 0

Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial ... Read More